“…Chronically implantable devices that stimulate the human brain are clinically approved to treat Parkinson’s disease, essential tremor, dystonia, epilepsy, and obsessive-compulsive disorder and have been investigated for major depressive disorder and Tourette syndrome (Lozano & Lipsman, 2013). Recent human studies have investigated the ability for direct stimulation of cortical and subcortical structures to modulate biomarkers of memory (Ezzyat et al, 2017; Inman et al, 2017), visual perception (Rangarajan et al, 2014; Winawer & Parvizi, 2016), language production (Chang, Kurteff, & Wilson, 2017), somatosensory perception (Muller et al, 2018), sensorimotor function (W. Wang et al, 2013), and subjective experience (Foster & Parvizi, 2017). While neurostimulation is a promising interventional approach to modulate brain state, current practices of calibrating where , when , and how to stimulate the brain are “open-loop” and limited in efficacy—relying on manual and periodic tuning of device parameters to optimize therapy (Morrell, 2011).…”